-
Mashup Score: 54Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography: - 3 day(s) ago
AbstractBackgroundThe effects of evolocumab on the underlying coronary disease activity by positron emission tomography (PET) and coronary tree plaque composition by coronary computed tomography an…
Source: www.jacc.orgCategories: General Medicine News, Partners & KOLsTweet
In stable patients with extensive noncalcified plaque volume at baseline, 18 months of evolocumab treatment was associated with a shift toward a lower risk quantitative plaque phenotype and a reduction in microcalcification activity. https://t.co/YNKq9wRsXc #JACCIMG #cvPET https://t.co/KwrzlWJYTm